Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F6X7Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,054
Award facts
- Contract value 100% obligated
- $11,053.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $11,053.70 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Jardiance 25 mg, a diabetes medication. The delivery order, awarded on January 22, 2026, with an ultimate completion date of January 23, 2026, carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen functions as a critical pharmaceutical distributor and healthcare solutions provider for federal medical procurement, particularly for military and veteran healthcare systems. The parent company Cencora, Inc. holds significant IDCs with both the Defense Logistics Agency and the Department of Justice Federal Bureau of Investigation, enabling the efficient fulfillment of government contracts for essential pharmaceutical and medical commodities required by military treatment facilities and other federal medical institutions. The delivery order for Jardiance represents a routine pharmaceutical supply transaction within AmerisourceBergen's extensive portfolio of federal medical product deliveries, which encompass a wide spectrum of medications across multiple therapeutic domains including diabetes, neurology, pain management, and oncology.
Quick answers
Who was awarded contract SPE2DR26F6X7Y?
SPE2DR26F6X7Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26F6X7Y worth?
The government has obligated $11,054 on SPE2DR26F6X7Y.
Is contract SPE2DR26F6X7Y an order under another contract?
Yes. SPE2DR26F6X7Y is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6X7Y competed?
The extent of competition for SPE2DR26F6X7Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award